1,4-Di-tert-Butyl 1,2,3,4-tetrahydropyrazine-1,4-dicarboxylate, 97%, 100mg

Hydroxyde de sodium, min 97%, pa, ACS, en pastilles, 5 kg, emballage plastique.

Cyclopropanecarbaldehyde, 95.0%, 1g

(S)-4-((tert-Butoxycarbonyl)amino)-4-phenylbutanoic acid, 97.0%, 250mg

2,4-Dibromo-6-fluoropyridin-3-ol, 95.0%, 1g

2-Hydrazinobenzoic acid hydrochloride, 97.0%, 10g

Flacons filetés 5000 ml

3-METHOXYAZETIDINE-3-CARBOXYLIC ACID HCL, 95.0%, 1g

Sulfate de lanthane hydraté 99,9% 100 g

2H,2H,3H,3H-Perfluorooctanoic acid, 98%, 1g

(3-bromophenoxy)acetic acid, 95.0%, 25g

ethyl 2-(3,5-dibromo-1H-1,2,4-triazol-1-yl)acetate, 95.0%, 2g

tert-Butyl 4-[(1R)-1-hydroxyethyl]piperidine-1-carboxylate, 98%, 500mg